T 2200/17 (TENOFOVIR PRODRUG / GILEAD SCIENCES) of 08.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T220017.20210308
- Date of decision
- 8 March 2021
- Case number
- T 2200/17
- Petition for review of
- -
- Application number
- 01961695.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PRODRUGS OF PHOSPHONATE NUCLEOTIDE ANALOGUES AND METHODS FOR SELECTING AND MAKING SAME
- Applicant name
- GILEAD SCIENCES, INC.
- Opponent name
- Teva Pharmaceutical Industries Ltd
Swindell & Pearson Limited
STRAWMAN LIMITED
HEXAL PHARMA AG - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 87Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13(2)
- Keywords
- Priority - validity of priority date (yes)
Novelty - (yes)
Inventive step - (yes)
Unsubstantiated objection - admitted (no)
Submissions after summons - admitted (no) - Catchword
- -
Order
For these reasons it is decided that:
The appeals are dismissed.